Aethlon Medical Net Worth
Aethlon Medical Net Worth Breakdown | AEMD |
Aethlon Medical Net Worth Analysis
Aethlon Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Aethlon Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Aethlon Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Aethlon Medical's net worth analysis. One common approach is to calculate Aethlon Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Aethlon Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Aethlon Medical's net worth. This approach calculates the present value of Aethlon Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Aethlon Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Aethlon Medical's net worth. This involves comparing Aethlon Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Aethlon Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Aethlon Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aethlon Medical's net worth research are outlined below:
| Aethlon Medical is way too risky over 90 days horizon | |
| Aethlon Medical has some characteristics of a very speculative penny stock | |
| Aethlon Medical appears to be risky and price may revert if volatility continues | |
| Aethlon Medical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Aethlon Medical has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Cipriani Guy F. of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 |
Aethlon Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aethlon Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aethlon Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 26th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Know Aethlon Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aethlon Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aethlon Medical backward and forwards among themselves. Aethlon Medical's institutional investor refers to the entity that pools money to purchase Aethlon Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Group One Trading, Lp | 2024-09-30 | 1.2 K | Wells Fargo & Co | 2024-09-30 | 211 | Advisor Group Holdings, Inc. | 2024-09-30 | 149 | Bank Of America Corp | 2024-09-30 | 114 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 89.0 | Bartlett & Co Wealth Management Llc | 2024-09-30 | 26.0 | Truvestments Capital Llc | 2024-09-30 | 5.0 | Hanson Mcclain Inc | 2024-09-30 | 2.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 218.3 K | Geode Capital Management, Llc | 2024-09-30 | 98.4 K |
Follow Aethlon Medical's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.22 M.Market Cap |
|
Project Aethlon Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.48) | (1.55) | |
| Return On Capital Employed | (1.97) | (1.87) | |
| Return On Assets | (1.48) | (1.55) | |
| Return On Equity | (2.12) | (2.01) |
When accessing Aethlon Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Aethlon Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Aethlon Medical's profitability and make more informed investment decisions.
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.
Evaluate Aethlon Medical's management efficiency
Aethlon Medical has return on total asset (ROA) of (0.5046) % which means that it has lost $0.5046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0538) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 19, 2024, Return On Tangible Assets is expected to decline to -1.55. The current year's Return On Capital Employed is expected to grow to -1.87. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 326.7 K, whereas Intangible Assets are forecasted to decline to 1,045.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.29 | 2.41 | |
| Tangible Book Value Per Share | 2.29 | 2.41 | |
| Enterprise Value Over EBITDA | 0.01 | 0.01 | |
| Price Book Value Ratio | 0.75 | 0.79 | |
| Enterprise Value Multiple | 0.01 | 0.01 | |
| Price Fair Value | 0.75 | 0.79 | |
| Enterprise Value | -154.6 K | -146.8 K |
Aethlon Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 1.0661 | Revenue 574.2 K | Quarterly Revenue Growth 42.782 | Revenue Per Share 0.236 | Return On Equity (1.05) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aethlon Medical time-series forecasting models is one of many Aethlon Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aethlon Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Aethlon Medical Earnings per Share Projection vs Actual
Aethlon Medical Corporate Management
| Richard Tullis | Chief Science Officer and VP | Profile | |
| MBA BS | Chief Officer | Profile | |
| MD Fisher | Director CEO | Profile | |
| Steven MD | Chief Officer | Profile | |
| Lee Arnold | Chief Officer | Profile | |
| Sunil Sawhney | Head Studies | Profile |
Already Invested in Aethlon Medical?
The danger of trading Aethlon Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aethlon Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aethlon Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aethlon Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.